about
Post-translational modifications of intermediate filament proteins: mechanisms and functionsNuclear lamins and neurobiology.An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatinGlobal profiling of protein lipidation using chemical proteomic technologiesAge and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skinThe cellular mastermind(?)-mechanotransduction and the nucleus.Broken nuclei--lamins, nuclear mechanics, and disease.Rho-kinase: regulation, (dys)function, and inhibition.Brief overview of selected approaches in targeting pancreatic adenocarcinoma.Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.Selective Gas-Phase Oxidation and Localization of Alkylated Cysteine Residues in Polypeptide Ions via Ion/Ion Chemistry.Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts.Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria.Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice.N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
P2860
Q27004670-046804C6-5E27-4C6E-86FD-04D565671131Q34056472-8462500B-ABD0-4D34-81B0-25EDC4D63BA7Q34592855-0D5820E7-F332-42F9-8088-4F804CD6FFF2Q35057612-5511D956-8100-41AE-8A2E-5CE8C7EDCD02Q35579069-2DEDBF44-034F-4C70-B492-CAE978A17B27Q36113002-22C987B1-CD2F-4FFB-B8F0-7698F9BE1CD0Q37678536-89EA140E-A476-4208-9BE3-DDBF367B40BAQ38129373-EA929FA2-DBC7-4E76-AF8F-322A6688B4EAQ38199723-C4F00DBB-B1F3-47E9-868E-1CDDA6552ED2Q39316007-867014B0-FBF7-4DBD-8553-33D83DAEA4DAQ41499122-130A039D-F2A7-447F-9512-3FAFEF6ABFC2Q42371472-41F05081-7B7D-4E74-98CE-BEF6DF79D8C7Q46902686-AA619B07-F358-45FC-ABA1-8D98C61CAC27Q47239374-A21C3646-9935-41C1-A1E4-BF351B12FC3CQ47590580-2441E8D3-DF3F-43B9-91C1-903B5274E3FAQ50054188-670487B2-50BE-4808-9DD5-239B14583811Q51778118-A7145E9B-962B-4CDE-B8A9-116D1640B1D3
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting protein prenylation in progeria
@ast
Targeting protein prenylation in progeria
@en
Targeting protein prenylation in progeria
@nl
type
label
Targeting protein prenylation in progeria
@ast
Targeting protein prenylation in progeria
@en
Targeting protein prenylation in progeria
@nl
prefLabel
Targeting protein prenylation in progeria
@ast
Targeting protein prenylation in progeria
@en
Targeting protein prenylation in progeria
@nl
P2093
P2860
P1476
Targeting protein prenylation in progeria
@en
P2093
Hea-Jin Jung
Loren G Fong
Shao H Yang
P2860
P304
P356
10.1126/SCITRANSLMED.3005229
P407
P577
2013-02-01T00:00:00Z